Medical devices: what US businesses sold for

What is my medical devices business worth?

Medical devices businesses in the United States sold for a median of 14.0 times EBITDA (5+ deals of US$10 million to US$500 million, deals announced 2015 to 2019, every year we hold). The group is small, so no middle half is shown.

Deals updated October 2026

Part of Manufacturing.

By deal size

Each size band on its own. A band with too few deals shows no figure.

US$10 million to US$500 million
Median 14.0 times EBITDA (5+ deals of US$10 million to US$500 million, deals announced 2015 to 2019, every year we hold). The group is small, so no middle half is shown.
US$500 million to US$2 billion
Median 11.5 times EBITDA (5+ deals of US$500 million to US$2 billion, deals announced 2011 to 2018, every year we hold). The group is small, so no middle half is shown.
All deals
Median 15.0 times EBITDA. The middle half of deals ran from 11.5 to 21.0 times (10+ deals of all sizes, deals announced 2017 to 2025, the last ten years).

Pick an industry and a size. Enter your yearly earnings to see them at the multiples those businesses sold at. Nothing you enter leaves this page.

This is not a valuation. It is arithmetic on reported deals. A buyer sets the price after testing your earnings, customers and plan.

Medical devices: what buyers paid

In Medical devices, US deals in our database sold at a median of 14.0 times EBITDA.

This is a small group. Fewer than ten deals sit behind the figure, so no range is shown.

5+ deals, announced 2015 to 2019. Too few recent deals sit in this group, so it covers every year from 2015.

These are US deals in our database with a published value. Most come from bankers' opinions filed with US mergers, so they lean to larger businesses.

How these figures are made. Where these deals come from, and what they leave out, is on the method page.

These are US deals in our database with a published value. Most come from bankers' opinions filed with US mergers, so they lean to larger businesses.

Built by Andrew Wilson and Claire Grego, former partners of strategy consulting firms. Between them they have worked at Bain, BCG, Monitor Deloitte and Strategy&.